Key Points
- Insider purchase: Robert Hanson bought 96,000 shares of Dr. Martens on December 5 at GBX 79 per share, a total value of £75,840.
- Shares trade around GBX 77.80 (52‑week range GBX 43.02–100.87); the company shows high leverage (debt/equity 127.27), a P/E of 45.76 and reported quarterly EPS of GBX (0.90). Analysts maintain a consensus "Moderate Buy" (two Buys, two Holds) with a reported consensus price target of GBX 6,000.
Dr. Martens plc (LON:DOCS - Get Free Report) insider Robert Hanson bought 96,000 shares of the company's stock in a transaction on Friday, December 5th. The shares were acquired at an average price of GBX 79 per share, with a total value of £75,840.
Dr. Martens Trading Down 0.4%
Shares of LON DOCS opened at GBX 77.80 on Tuesday. Dr. Martens plc has a fifty-two week low of GBX 43.02 and a fifty-two week high of GBX 100.87. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The company has a market cap of £751.82 million, a price-to-earnings ratio of 45.76, a PEG ratio of 6.40 and a beta of 0.11. The business's 50 day moving average price is GBX 86.39 and its 200-day moving average price is GBX 82.22.
Dr. Martens (LON:DOCS - Get Free Report) last announced its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) EPS for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, sell-side analysts expect that Dr. Martens plc will post 2.5809394 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on DOCS. Peel Hunt restated a "buy" rating on shares of Dr. Martens in a report on Thursday, November 20th. Berenberg Bank restated a "buy" rating on shares of Dr. Martens in a research note on Thursday, November 27th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Dr. Martens currently has a consensus rating of "Moderate Buy" and a consensus price target of GBX 6,000.
Check Out Our Latest Research Report on DOCS
About Dr. Martens
(
Get Free Report)
Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
